Cutera (CUTR) Competitors

$2.21
-0.13 (-5.56%)
(As of 02:45 PM ET)

CUTR vs. IRIX, EGIO, PHUN, REFR, GAN, ONDS, RNLX, CMTL, LPSN, and MCHX

Should you be buying Cutera stock or one of its competitors? The main competitors of Cutera include IRIDEX (IRIX), Edgio (EGIO), Phunware (PHUN), Research Frontiers (REFR), GAN (GAN), Ondas (ONDS), Renalytix (RNLX), Comtech Telecommunications (CMTL), LivePerson (LPSN), and Marchex (MCHX). These companies are all part of the "computer and technology" sector.

Cutera vs.

Cutera (NASDAQ:CUTR) and IRIDEX (NASDAQ:IRIX) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations.

Cutera received 62 more outperform votes than IRIDEX when rated by MarketBeat users. However, 69.74% of users gave IRIDEX an outperform vote while only 64.98% of users gave Cutera an outperform vote.

CompanyUnderperformOutperform
CuteraOutperform Votes
334
64.98%
Underperform Votes
180
35.02%
IRIDEXOutperform Votes
272
69.74%
Underperform Votes
118
30.26%

90.7% of Cutera shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 2.1% of Cutera shares are owned by company insiders. Comparatively, 6.2% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Cutera had 2 more articles in the media than IRIDEX. MarketBeat recorded 5 mentions for Cutera and 3 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.47 beat Cutera's score of -0.25 indicating that IRIDEX is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cutera
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IRIDEX
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

IRIDEX has lower revenue, but higher earnings than Cutera. IRIDEX is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cutera$212.37M0.20-$150.83M-$7.34-0.29
IRIDEX$51.87M0.88-$9.57M-$0.59-4.78

Cutera currently has a consensus target price of $12.67, indicating a potential upside of 441.31%. IRIDEX has a consensus target price of $2.00, indicating a potential downside of 29.82%. Given Cutera's higher probable upside, research analysts plainly believe Cutera is more favorable than IRIDEX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cutera
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
IRIDEX
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

IRIDEX has a net margin of -18.45% compared to Cutera's net margin of -68.87%. Cutera's return on equity of 0.00% beat IRIDEX's return on equity.

Company Net Margins Return on Equity Return on Assets
Cutera-68.87% N/A -34.04%
IRIDEX -18.45%-75.18%-25.99%

Cutera has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.

Summary

Cutera beats IRIDEX on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CUTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CUTR vs. The Competition

MetricCuteraElectromedical equipment IndustryComputer SectorNASDAQ Exchange
Market Cap$42.08M$3.25B$19.75B$7.77B
Dividend YieldN/A1.69%2.75%3.96%
P/E Ratio-0.2910.02267.8618.93
Price / Sales0.2062.64523.1588.59
Price / CashN/A66.1228.5028.61
Price / Book-0.263.986.794.58
Net Income-$150.83M$87.99M$630.14M$217.41M
7 Day Performance-16.60%1.10%0.75%0.09%
1 Month Performance20.57%-7.81%0.04%-1.15%
1 Year Performance-88.05%2.13%29.48%8.55%

Cutera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRIX
IRIDEX
0.0787 of 5 stars
$2.80
-0.4%
$2.00
-28.6%
+22.3%$45.50M$51.87M-4.75111Short Interest ↓
EGIO
Edgio
0.7572 of 5 stars
$9.35
-0.5%
$33.33
+256.5%
-61.1%$54.51M$403.59M-0.37822Short Interest ↑
PHUN
Phunware
2.5498 of 5 stars
$6.89
-0.4%
$19.00
+175.8%
-75.3%$55.33M$4.83M-0.3725Earnings Report
News Coverage
Gap Down
REFR
Research Frontiers
0 of 5 stars
$1.62
+0.6%
N/A+29.0%$54.30M$910,000.00-32.406News Coverage
GAN
GAN
0 of 5 stars
$1.20
+0.8%
N/A-20.1%$54.13M$129.42M-1.54673Earnings Report
Short Interest ↑
ONDS
Ondas
2.0305 of 5 stars
$0.82
-1.2%
$2.75
+235.0%
-32.9%$53.86M$15.69M-0.92116
RNLX
Renalytix
1.5194 of 5 stars
$0.69
flat
$5.00
+623.1%
-74.9%$53.37M$3.40M-1.54102Upcoming Earnings
News Coverage
CMTL
Comtech Telecommunications
3.3976 of 5 stars
$1.99
-4.3%
$12.25
+515.6%
-84.6%$56.66M$549.99M-1.171,718Short Interest ↑
News Coverage
LPSN
LivePerson
2.667 of 5 stars
$0.59
flat
$2.58
+336.6%
-86.7%$52.14M$401.98M-0.471,095Analyst Forecast
Short Interest ↑
News Coverage
MCHX
Marchex
0.8948 of 5 stars
$1.34
-2.9%
N/A-26.1%$58.50M$49.91M-5.83164Analyst Forecast
News Coverage

Related Companies and Tools

This page (NASDAQ:CUTR) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners